Daphne Day

13PUBLICATIONS
24CO-AUTHORS
Molecular targetsCancer geneticsCultural theoryMedical genetics (excl. cancer genetics)Pacific Peoples theory of change models for health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Apr 15, 2025
First-in-human phase I study of EMB-02, a bispecific antibody targeting PD-1 and LAG-3 in patients with advanced solid tumors.

Daphne Day, Vinod Ganju, Ki Chung

|Aug 28, 2024
Equitable Access to Genomic Molecular Testing for Australian Cancer Patients: Insights from the Victorian Precision Oncology Summit.

Genevieve Dall, Karen Harris, Nonie Chan

|Jun 27, 2024
COVID-19 Vaccine Acceptance, Hesitancy, and Uptake in People with Diabetes in Australia.

Holly Wang, Lisa Grech, Jennifer Wong

|Sep 21, 2023
A first-in-human phase 1 study of nofazinlimab, an anti-PD-1 antibody, in advanced solid tumors and in combination with regorafenib in metastatic colorectal cancer.

Daphne Day, John J Park, Jermaine Coward

|Jun 26, 2023
Operational Challenges of an Asia-Pacific Academic Oncology Clinical Trial.

Daphne Day, Han Chong Toh, Raghib Ali

|Feb 28, 2023
Factors Influencing COVID-19 Vaccine Hesitancy among Patients with Serious Chronic Illnesses during the Initial Australian Vaccine Rollout: A Multi-Centre Qualitative Analysis Using the Health Belief Model.

Tammie Choi, Bryan Chan, Lisa Grech

Pageof 3

Frequent Collaborators

8 joint publications

Eva Segelov

4 joint publications

Mike Nguyen

4 joint publications

Kate Webber

3 joint publications

Lisa Grech